QualityStocksNewsBreaks Archives

MondayApr 13, 2026 1:13 pm

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Reports Strong Cyanide Extraction Results at West Santa Fe Project

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) announced that cyanide extraction testing from its 2025 reverse-circulation drilling program at the West Santa Fe project demonstrated high recovery rates, with gold averaging 81% and silver 60%, exceeding prior metallurgical projections and supporting heap leach processing potential. The results validate historical and recent testing, reinforce the project’s amenability to cost-effective recovery methods and support continued exploration aimed at expanding the mineralized footprint ahead of a planned Mineral Resource Estimate later this year. To view the full press release, visit https://ibn.fm/U7D1a About Lahontan Gold Corp. Lahontan Gold Corp. is…

MondayApr 13, 2026 12:26 pm

QualityStocksNewsBreaks – Xeriant, Inc. (OTCQB: XERI) Advances NEXBOARD(TM) Toward Certification Following Internal Fire Testing

Xeriant (OTCQB: XERI), a company focused on developing and commercializing advanced technologies, announced the completion of a critical phase of internal testing for its NEXBOARD(TM) composite building panel, demonstrating strong fire-resistant performance ahead of third-party certification. The company is preparing for formal NFPA 286 and ASTM E84 testing, following internal trials showing no combustion or smoke under extreme heat, while refining manufacturing processes to support scalable production as it moves toward commercialization and broader adoption in residential and commercial construction. To view the full press release, visit https://ibn.fm/yB56b About Xeriant, Inc. Xeriant, Inc. is dedicated to the discovery, development and commercialization of transformative technologies, including advanced materials, which can be…

MondayApr 13, 2026 11:59 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints First Chief Commercial Officer Ahead of Ketamine Launch

NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression, PTSD and related conditions, announced the appointment of Glenn Tyson as its first Chief Commercial Officer as the company prepares for anticipated approval of its Abbreviated New Drug Application for a preservative-free ketamine product. Tyson brings more than 25 years of commercialization and sales experience, including senior leadership roles at GSK and Indivior, where he led the successful launch of SUBLOCADE(R), and will oversee the buildout of market access, distribution, sales and marketing capabilities to support upcoming product launches and the company’s broader psychiatry pipeline, including NRX-100 and NRX-101. To…

MondayApr 13, 2026 11:46 am

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Launches NODE-X AI Edge Processor for Drone Threat Detection

Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security and situational awareness solutions, announced the commercial rollout of its NODE-X, a next-generation, miniaturized AI-powered edge compute processor designed to analyze drone footage for real-time threat detection in military missions, following a recent government contract award. The backpack-deployable system leverages the company’s patented SPOTD technology trained on millions of real-world images to detect threats such as landmines, UXO and drones, while generating 3D mapping and route guidance without connectivity, and is scheduled for additional U.S. Army exercises through the second quarter of 2026 as Safe Pro scales production to meet…

MondayApr 13, 2026 11:28 am

QualityStocksNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company advancing cancer treatments, announced preliminary results from a clinical trial evaluating its proprietary compound LB-100 in combination with dostarlimab at the 2026 Society of Gynecologic Oncology conference in San Juan, Puerto Rico. Interim data from 20 evaluable patients showed a 40% disease control rate and encouraging survival trends with an acceptable safety profile, supporting continued enrollment of an expanded cohort as the company investigates the combination’s potential to enhance immunotherapy response in ovarian clear cell carcinoma. To view the full press release, visit https://ibn.fm/qhQl9 About LIXTE Biotechnology Holdings, Inc. LIXTE Biotechnology Holdings, Inc. is a clinical-stage…

MondayApr 13, 2026 11:00 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) to List Meme Coin, RWA Token Portfolio on Biconomy Exchange

Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced plans to list its proprietary meme coin portfolio and RWA token suite on the Biconomy exchange, targeting expanded liquidity and distribution across Southeast Asian and global markets. The listings will include Dream Bowl and Josh Gibson-themed digital assets alongside RWA stablecoins, building on the company’s existing TRITON token already trading on Biconomy, as Datavault advances its tokenization pipeline and broader Information Data Exchange strategy while leveraging the platform’s global user base and trading volume to drive adoption visibility for emerging football talent through a broad sports and entertainment audience. To…

MondayApr 13, 2026 9:40 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Develops Intox Collect(TM) to Scale AI Voice-Based Intoxication Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) a biotechnology company focused on AI-driven voice analytics for intoxication detection, announced the completion of its Intox Collect(TM) technology, enabling rapid scaling of data collection and analysis across a wide range of substances using voice and facial recognition. The platform enhances the company’s ability to train its AI model, which leverages more than 50 million data points to predict drug and alcohol intoxication through voice with high accuracy, while supporting expansion into regulated industries such as…

MondayApr 13, 2026 9:10 am

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Begins 2026 Exploration Program at Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based phosphate exploration company, announced the start of its 2026 exploration program at the Murdock Mountain Phosphate Project in northeastern Nevada following completion of required wildlife and sage-grouse pre-clearance surveys. The company is advancing drill pad construction and preparing to resume drilling to evaluate strike extent, thickness, continuity and grade of the phosphate zone, building on consistent mineralization identified in 2025, as it works to refine its geological model and support future resource classification while…

MondayApr 13, 2026 9:00 am

QualityStocksNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Secures Repeat Defense Order for DefendAir CUAS System

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company specializing in autonomous solutions for manned and unmanned aerial systems, announced it has received a second purchase order from a defense entity for its DefendAir Counter-Unmanned Aerial Systems solution following prior evaluation and training. The order includes Personal Net Launchers, net pods and a comprehensive training package designed to support rapid deployment and operational readiness, reinforcing ParaZero’s growing presence with defense partners and highlighting demand for its non-kinetic, multi-layered drone interception technology, which has demonstrated 100% success in field trials and supports flexible configurations for urban, battlefield and infrastructure protection. To view…

FridayApr 10, 2026 1:44 pm

QualityStocksNewsBreaks – Xanadu Quantum Technologies Limited (NASDAQ, TSX: XNDU) Surges Over 20% On Strong Intraday Trading

This article has been disseminated on behalf of Xanadu Quantum Technologies Limited and may include paid advertising. Xanadu Quantum Technologies (NASDAQ, TSX: XNDU) shares jumped more than 20% in active trading, climbing to $9.31 from a previous close of $7.65, with the stock reaching an intraday high of $9.33 as momentum accelerated through midday. The move comes amid elevated volume and continued investor interest in quantum computing plays, positioning XNDU near the upper end of its recent trading range as market participants respond to growing enthusiasm around the sector. About Xanadu Xanadu is a Canadian quantum computing company with the mission to build quantum computers that are useful and…

Site Search

Company Search

Category: QualityStocksNewsBreaks